CELUW vs CTAS · rev $54.2M vs P/E 51, rev $11.26B
Celularity Inc (CELUW) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Celularity Inc (CELUW) common stock listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
CELUW currently screens at market cap $0. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the CELUW and CTAS stock pages for the full models.
Not investment advice.